Tfc Financial Management Dexcom Inc Transaction History

Tfc Financial Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$75.49 - $124.16 $75 - $124	1 Added 7.14%	15 $1,000
Q3 2023 Oct 23, 2023	BUY	$86.06 - $137.93 $86 - $137	1 Added 7.69%	14 $1,000
Q2 2023 Aug 07, 2023	SELL	$112.47 - $130.98 $37,227 - $43,354	-331 Reduced 96.22%	13 $1,000
Q1 2023 May 08, 2023	BUY	$104.0 - $122.92 $35,048 - $41,424	337 Added 4814.29%	344 $39,000
Q3 2022 Oct 21, 2022	BUY	$76.35 - $94.18 $534 - $659	7 New	7 $1,000
Q4 2020 Feb 10, 2021	SELL	$78.0 - $104.5 $468 - $627	-6 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $573 - $677	6 New	6 $2,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

Stay updated on Tfc Financial Management with notifications on news.